Spruce Biosciences Inc (SPRB)

$0.08 +0.00 (5.47%)
Market Cap 3.32M
Revenue (ttm) 4.91M
Net Income (ttm) -53.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,080.24%
Debt to Equity Ratio 0.06
Volume 4,396,400
Avg Vol 1,630,932
Day's Range N/A - N/A
Shares Out 42.23M
Stochastic %K 30%
Beta 2.39
Analysts Hold
Price Target $1.50

Company Profile

Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, includ...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 655 4168
Address:
611 Gateway Boulevard, Suite 740, South San Francisco, United States
Monsters_of_Swing
Monsters_of_Swing Jul. 15 at 5:14 PM
$SPRB the fake pump seems to be over once again back to reality
0 · Reply
theflynews
theflynews Jul. 14 at 4:15 PM
Biotech Alert: Searches spiking for these stocks today - $SPRB - https://thefly.com/permalinks/entry.php/SPRBid4158973?1752509656C38
0 · Reply
joe77w
joe77w Jul. 14 at 4:13 PM
$SPRB NASDAQ RELISTING, UPDATE ABOUT TRIAL AND BLA, FUNDING...A lot really a lot of catalysts, trading for 4 mln usd vs 20 mln in net cash or 50 cents in cash, not accounting for a huge pipeline with 3 compounds. Company could have first orphan drug for rare disease approved next year and trading for 4 mln usd🤔☹️🤬😄💰💰💰💰💰 I really dont understand
0 · Reply
keokeostwiz
keokeostwiz Jul. 14 at 3:19 PM
$SPRB Nobody wanted this at .07 but interested at .11....waiting for finance news to appear....JMO
0 · Reply
keokeostwiz
keokeostwiz Jul. 11 at 8:23 PM
$SPRB Finance deal must be on the horizon to cause a sleeping giant to interrupt a long comatose pose with a sudden murmur of anticipation.......JMO
0 · Reply
joe77w
joe77w Jul. 11 at 5:31 PM
$SPRB just a matter of weeks and then again listed on NASDAQ
0 · Reply
joe77w
joe77w Jul. 11 at 4:58 PM
$SPRB One of the most undervalued stock, trading at a fraction of cash and with a huge pipeline, add the very likely approval in 2026 of Orphan drug inlicensed by Biomarin, Priority Review Voucher and NASDAQ relisting in August, 50 cents in cash and trading for 10 Just my opinion, once relisted and with approval will be worth hundreds of million market cap stock
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Jul. 11 at 4:53 PM
$SPRB 👀 👁 👀 👁 👀 👁
1 · Reply
keokeostwiz
keokeostwiz Jul. 11 at 3:58 PM
$SPRB Heartbeat detected in neglected cadaver....someone attempting CPR
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 30 at 5:51 PM
$SPRB place your bets on the reverse-split ratio , anything less than 1:100 would be a suprise
1 · Reply
Latest News on SPRB
No data available.
Monsters_of_Swing
Monsters_of_Swing Jul. 15 at 5:14 PM
$SPRB the fake pump seems to be over once again back to reality
0 · Reply
theflynews
theflynews Jul. 14 at 4:15 PM
Biotech Alert: Searches spiking for these stocks today - $SPRB - https://thefly.com/permalinks/entry.php/SPRBid4158973?1752509656C38
0 · Reply
joe77w
joe77w Jul. 14 at 4:13 PM
$SPRB NASDAQ RELISTING, UPDATE ABOUT TRIAL AND BLA, FUNDING...A lot really a lot of catalysts, trading for 4 mln usd vs 20 mln in net cash or 50 cents in cash, not accounting for a huge pipeline with 3 compounds. Company could have first orphan drug for rare disease approved next year and trading for 4 mln usd🤔☹️🤬😄💰💰💰💰💰 I really dont understand
0 · Reply
keokeostwiz
keokeostwiz Jul. 14 at 3:19 PM
$SPRB Nobody wanted this at .07 but interested at .11....waiting for finance news to appear....JMO
0 · Reply
keokeostwiz
keokeostwiz Jul. 11 at 8:23 PM
$SPRB Finance deal must be on the horizon to cause a sleeping giant to interrupt a long comatose pose with a sudden murmur of anticipation.......JMO
0 · Reply
joe77w
joe77w Jul. 11 at 5:31 PM
$SPRB just a matter of weeks and then again listed on NASDAQ
0 · Reply
joe77w
joe77w Jul. 11 at 4:58 PM
$SPRB One of the most undervalued stock, trading at a fraction of cash and with a huge pipeline, add the very likely approval in 2026 of Orphan drug inlicensed by Biomarin, Priority Review Voucher and NASDAQ relisting in August, 50 cents in cash and trading for 10 Just my opinion, once relisted and with approval will be worth hundreds of million market cap stock
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Jul. 11 at 4:53 PM
$SPRB 👀 👁 👀 👁 👀 👁
1 · Reply
keokeostwiz
keokeostwiz Jul. 11 at 3:58 PM
$SPRB Heartbeat detected in neglected cadaver....someone attempting CPR
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 30 at 5:51 PM
$SPRB place your bets on the reverse-split ratio , anything less than 1:100 would be a suprise
1 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 18 at 6:10 PM
$SPRB the euphoria about the pending return to NASDAQ is truly breathtaking
0 · Reply
Stmkr
Stmkr Jun. 17 at 3:07 PM
$SPRB https://www.fda.gov/news-events/press-announcements/fda-issue-new-commissioners-national-priority-vouchers-companies-supporting-us-national-interests
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 17 at 2:45 PM
$SPRB at least the market does not seem to believe in their return to NASDAQ
0 · Reply
keokeostwiz
keokeostwiz Jun. 17 at 5:48 AM
$SPRB It will all be decided by the scope of financial assets that management is able to access inorder to complete strategic objectives of monetizing priority review voucher and securing orphan drug approval as a bundle of money will be necessary to fuel advance of these projects...the ability to snare a large suitor with deep assets is essential to insure the future existence of the company.....would like to see the announcement of a financial settlement before reverse split to provide a pathway to attract needed new investors and maintain continuity in research and development as it certainly feels like a long shot possibility....holding a very large position at an average of .26 cents justified by the estimated 20 million cash on hand and the expectancy of some kind of financing being acquired with anticipation of a bump when reverse split occurs accompanied by new financing.......JMO
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Jun. 16 at 6:58 PM
$SPRB i'm posting this here and here only $BCYC negative EV a whole bunch of programs (check their website) baker brothers bought in at much higher prices felix baker taking over as chairman today do your own research I added today
5 · Reply
Ridiculous78
Ridiculous78 Jun. 16 at 2:47 PM
$SPRB Seems like they want to get relisted on the Nasdaq. Institutions still holding roughly 20%, severely bagged. Adding a couple thousand at .07c in the event of a RS / relist / pump into cash raise (likely).
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 13 at 2:58 PM
$SPRB buying interest near zero nobody seems to believe in their fantasies
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Jun. 13 at 1:48 PM
$SPRB as expected - the fake pump is over
1 · Reply
joe77w
joe77w Jun. 12 at 8:37 PM
$SPRB after ER THERAPY approval, Company could be worth north of 300 mln usd so I dont care about offering, when orphan drug approved, and Priority review voucher granted, 80% chance approval
0 · Reply
joe77w
joe77w Jun. 12 at 6:55 PM
$SPRB the most undervalued stock, I would buy a ton at this silly price. Huge catalysts ahead, trading at a fraction of cash, rare disease drig potential approval next year with Priority Review Voucher worth 150 mln usd. Current market cap 3 mln usd woth 20 mln in net cash, absurd
1 · Reply
joe77w
joe77w Jun. 12 at 3:04 PM
$SPRB .25 again when relisted, one of the most undervalued stock on the earth imo
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Jun. 12 at 2:56 PM
$SPRB please, will anyone raise their hand and admit they just sold their shares on that sucker pop? please even one of you guys ? shares will in all likelihood be .06 again
1 · Reply